Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 11120891.
- Also identified by PMC identifier 14632.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We hypothesize that loss of imprinting (LOI) of the insulin-like growth factor II (IGF2) gene is associated with a predisposition to sporadic colorectal cancer. We confirmed a previously known strong correlation between LOI and microsatellite instability and showed that LOI was not a consequence of microsatellite instability or mismatch repair deficiency. LOI of IGF2 correlated strongly with biallelic hypermethylation of a core of five CpG sites in the insulator region of IGF2/H19, which is a known CTCF-binding element. As this methylation-dependent LOI was present in both tumors and normal colonic mucosa, it is possible that hypermethylation creates a field defect predisposing to cancer.
Medical subject headings
- Adenocarcinoma
- Colorectal Neoplasms
- CpG Islands
- DNA Methylation
- DNA-Binding Proteins
- Gene Expression Regulation, Neoplastic
- Genes, Regulator
- Genomic Imprinting
- Insulin-Like Growth Factor II
- RNA, Untranslated
- Repressor Proteins
- Transcription Factors